These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8561838)

  • 21. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
    Bowden CL; Brugger AM; Swann AC; Calabrese JR; Janicak PG; Petty F; Dilsaver SC; Davis JM; Rush AJ; Small JG
    JAMA; 1994 Mar 23-30; 271(12):918-24. PubMed ID: 8120960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalproex sodium treatment in late adolescent and young adult acute mania.
    Papatheodorou G; Kutcher SP
    Psychopharmacol Bull; 1993; 29(2):213-9. PubMed ID: 8290668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use and tolerability of fluoxetine in geropsychiatric inpatients.
    Orengo CA; Kunik ME; Molinari V; Workman RH
    J Clin Psychiatry; 1996 Jan; 57(1):12-6. PubMed ID: 8543541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divalproex sodium as a treatment for borderline personality disorder.
    Wilcox JA
    Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerability of clonazepam in demented and non-demented geropsychiatric patients.
    Calkin PA; Kunik ME; Orengo CA; Molinari V; Workman R
    Int J Geriatr Psychiatry; 1997 Jul; 12(7):745-9. PubMed ID: 9251937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
    J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    Davis LL; Bartolucci A; Petty F
    J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
    Smith MC; Centorrino F; Welge JA; Collins MA
    Epilepsy Behav; 2004 Oct; 5(5):746-51. PubMed ID: 15380129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
    Iqbal SU; Cunningham F; Lee A; Wang S; Hamed A; Miller DR; Ren X; Kazis L
    J Clin Pharm Ther; 2007 Dec; 32(6):625-32. PubMed ID: 18021341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of serum valproate concentration to response in mania.
    Bowden CL; Janicak PG; Orsulak P; Swann AC; Davis JM; Calabrese JR; Goodnick P; Small JG; Rush AJ; Kimmel SE; Risch SC; Morris DD
    Am J Psychiatry; 1996 Jun; 153(6):765-70. PubMed ID: 8633687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome with divalproex in children and adolescents with bipolar disorder.
    Henry CA; Zamvil LS; Lam C; Rosenquist KJ; Ghaemi SN
    J Child Adolesc Psychopharmacol; 2003; 13(4):523-9. PubMed ID: 14977465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.